Skip to content
Open access

Conditional survival nomogram for dynamic prognostic prediction in older women with surgically treated breast cancer.

Jul 2026 · Biomolecules & biomedicine · 0 citations
Medicine

TL;DR

This internally validated nomogram provides individualized, time-updated BCSS estimates and may support dynamic risk stratification during long-term follow-up, although external validation is required before clinical implementation.

Abstract

Prognostic estimates established at breast cancer diagnosis may become less informative as patients survive longer, particularly among older women with substantial competing mortality risks. This study aimed to develop and internally validate a dynamic conditional survival (CS) nomogram for predicting breast cancer-specific survival (BCSS) in surgically treated women aged ≥70 years. Data were obtained from the Surveillance, Epidemiology, and End Results (SEER) database for patients diagnosed between 2010 and 2015. The 44,354 eligible patients were randomly assigned to training (n = 31,047) and internal validation (n = 13,307) cohorts. A random survival forest (RSF) algorithm was used to select prognostic variables, which were incorporated into a multivariable Cox regression model to construct a nomogram combining conventional and conditional BCSS estimates. Model performance was evaluated using the concordance index (C-index), time-dependent receiver operating characteristic curves, calibration analysis, and decision curve analysis. The RSF algorithm selected age, T stage, N stage, M stage, histological grade, and molecular subtype as independent predictors of BCSS. The estimated probability of surviving to 10 years increased from 88% at diagnosis to 89%, 92%, 95%, and 97% after surviving 1, 3, 5, and 7 years, respectively. The model achieved C-indices of 0.833 and 0.830 in the training and validation cohorts, respectively, with time-dependent areas under the curve ranging from 0.841 to 0.882. Calibration was satisfactory, and the nomogram provided greater net benefit than tumor-node-metastasis staging alone. This internally validated nomogram provides individualized, time-updated BCSS estimates and may support dynamic risk stratification during long-term follow-up, although external validation is required before clinical implementation.

Read PDF

Similar papers

Open access Sep 2026

Development and Validation of a Competing-Risk Nomogram for Predicting Breast Cancer–Specific Survival in Young Women with Early-Stage Breast Cancer: A SEER-Based Study

Background & Objective: Breast cancer in women aged ≤40 years is biologically aggressive and carries a disproportionate cancer-specific mortality risk. Existing prognostic tools predominantly predict overall survival, rarely account for competing risks of non-cancer death, and have not evaluated whether primary treatme...

Umema Tariq, Yousaf Ali, Mohammad Idrees et al. · 0 citations
Open access Sep 2026

Development and internal validation of prognostic nomograms for overall and breast cancer-specific survival in de novo stage IV HER2-positive breast cancer.

The nomograms showed good internal discrimination and may support individualized prognostic assessment once initial treatment information is available, and 5-year estimates should be interpreted cautiously given the median follow-up of 27 months.

Xiao-Jie Yu, De-Yuan Fu, L. Yao · 0 citations
Sep 2026

Construction and Validation of a Nomogram Model for Predicting Cancer-Specific Survival in Colorectal Cancer Based on the SEER Database.

BACKGROUND Colorectal cancer (CRC) remains one of the most prevalent malignancies worldwide, and accurate prognostic prediction is essential for individualized prognostic assessment and patient risk communication. The conventional TNM staging system has limited capacity for personalized survival estimation. This study...

Yi Liu, Xiao-Jun Tang, Zhi Liu et al. · 0 citations
Open access Sep 2026

Conditional cancer-specific survival in breast cancer with de novo bone metastases: A SEER-based study.

Baseline survival estimates do not capture evolving prognosis in breast cancer with de novo bone metastases. We aimed to develop and internally evaluate a prognostic framework integrating baseline and conditional cancer-specific survival (CSS) estimates. Using the Surveillance, Epidemiology, and End Results (SEER) data...

Shi-Long Wang, Long Jia · 0 citations
Open access Jan 2026

Web-based dynamic nomogram for forecasting overall survival and cancer-specific survival among individuals with lymph node-negative pancreatic cancer: based upon the SEER database

Highlights • Developed nomograms predicting OS and CSS in LN-negative pancreatic cancer.• The Fine‑Gray model improved accuracy of cancer-specific survival estimates.• Nomograms integrated key clinicopathological factors with high predictive accuracy.• An online calculator enables individualized prognosis assessment in...

Zhe-Yuan Wang, Lu Zhang, Zeng-You Li et al. · 0 citations
Open access Sep 2026

Analysis of prognostic factors in patients with locally advanced cervical squamous cell carcinoma and development of a nomogram prediction model

A clinical predictive model was established to estimate 3-, 4-, and 5-year survival rates for LACSC patients and exhibited significantly poorer overall survival in both cohorts (P < 0.05).

Ting-Ting Zou, Xu-Peng Wang, Hai-Xia Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.